Mucosal Innate Immune Factors in the Female Genital Tract Are Associated with Vaginal HIV-1 Shedding Independent of Plasma Viral Load
- 1 August 2006
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 22 (8) , 788-795
- https://doi.org/10.1089/aid.2006.22.788
Abstract
Recent studies indicate that mucosal innate immune factors modulate HIV-1 infection in vitro. Our interest was to examine the levels of innate mucosal factors for their potential association with HIV-1 shedding in the female genital tract. Vaginal lavages were collected from HIV-1-infected women who had vaginal viral loads (VVL) that were below, within, or above the 90% confidence interval (CI) predicted by their matched plasma viral loads. Innate immune factors [cathepsin D, lactoferrin (Lf), myeloid related protein (MRP)-8, MRP-8/14, secretory leukocyte protease inhibitor, and gp340], cytokines (IL-1β and TNF-α), and chemokines (MIP-1α, MIP-1β, RANTES, and SDF-1α) were quantified by ELISA. Leukocyte levels were determined using a leukocyte reagent strip for urinalysis. Lf, MRP-8/14, gp340, and IL-1β levels were significantly higher in vaginal lavages above the 90% CI and generally correlated with each other and with VVL. Leukocyte levels were significantly higher in the lavages that had virus shedding above the 90% CI and correlated strongly with Lf levels and VVL. In this group of women, these results suggest that the levels of certain innate immune factors are more closely associated with HIV-1 shedding in the genital mucosa than plasma virus concentrations.Keywords
This publication has 47 references indexed in Scilit:
- DMBT1, a regulator of mucosal homeostasis through the linking of mucosal defense and regeneration?FEBS Letters, 2003
- Salivary Agglutinin Inhibits HIV Type 1 Infectivity through Interaction with Viral Glycoprotein 120AIDS Research and Human Retroviruses, 2003
- The Menstrual Cycle Does Not Affect Human Immunodeficiency Virus Type 1 Levels in Vaginal SecretionsThe Journal of Infectious Diseases, 2002
- Variation of Human Immunodeficiency Virus Type 1 Viral RNA Levels in the Female Genital Tract: Implications for Applying Measurements to Individual WomenThe Journal of Infectious Diseases, 2001
- Chronic Inflammation with Increased Human Immunodeficiency Virus (HIV) RNA Expression in the Vaginal Epithelium of HIV‐Infected Thai WomenThe Journal of Infectious Diseases, 2001
- Novel roles of protease inhibitors in infection and inflammationBiochemical Society Transactions, 2001
- Cervical Human Immunodeficiency Virus Type 1 Shedding Is Associated with Genital β‐Chemokine SecretionThe Journal of Infectious Diseases, 1998
- Heterosexual Transmission of Human Immunodeficiency Virus: Variability of Infectivity throughout the Course of InfectionAmerican Journal of Epidemiology, 1998
- Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type 1Oral Diseases, 1997
- Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms.The Journal of Experimental Medicine, 1990